Skip to main content
. Author manuscript; available in PMC: 2022 Dec 8.
Published in final edited form as: ACS Nano. 2021 Dec 6;15(12):20504–20516. doi: 10.1021/acsnano.1c09064

Figure 4.

Figure 4.

Hyaluronic acid peptide targeting increases overall TBI-ABN activation and distribution within coronal sections of the injured hemisphere. Injured hemispheres from CCI-injured mice (representative brains from triplicate) after intravenous administration of vehicle or nanosensors with non-, moderate- or high-targeting modification (blue, nuclei; magenta, activated nanosensor; green, HApep on nanosensor; scale bar = 500 μm).